Endocrinology Unit, Centre for Cardiovascular Sciences, Queens Medical Research Institute, University of Edinburgh, Edinburgh, United Kingdom.
Am J Physiol Endocrinol Metab. 2011 Jun;300(6):E1076-84. doi: 10.1152/ajpendo.00531.2010. Epub 2011 Mar 15.
Increased dietary fat intake is associated with obesity, insulin resistance, and metabolic disease. In transgenic mice, adipose tissue-specific overexpression of the glucocorticoid-amplifying enzyme 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) exacerbates high-fat (HF) diet-induced visceral obesity and diabetes, whereas 11β-HSD1 gene knockout ameliorates this, favoring accumulation of fat in nonvisceral depots. Paradoxically, in normal mice HF diet-induced obesity (DIO) is associated with marked downregulation of adipose tissue 11β-HSD1 levels. To identify the specific dietary fats that regulate adipose 11β-HSD1 and thereby impact upon metabolic disease, we either fed mice diets enriched (45% calories as fat) in saturated (stearate), monounsaturated (oleate), or polyunsaturated (safflower oil) fats ad libitum or we pair fed them a low-fat (11%) control diet for 4 wk. Adipose and liver mass and glucocorticoid receptor and 11β-HSD1 mRNA and activity levels were determined. Stearate caused weight loss and hypoinsulinemia, partly due to malabsorption, and this markedly increased plasma corticosterone levels and adipose 11β-HSD1 activity. Oleate induced pronounced weight gain and hyperinsulinemia in association with markedly low plasma corticosterone and adipose 11β-HSD1 activity. Weight gain and hyperinsulinemia was less pronounced with safflower compared with oleate despite comparable suppression of plasma corticosterone and adipose 11β-HSD1. However, with pair feeding, safflower caused a selective reduction in visceral fat mass and relative insulin sensitization without affecting plasma corticosterone or adipose 11β-HSD1. The dynamic depot-selective relationship between adipose 11β-HSD1 and fat mass strongly implicates a dominant physiological role for local tissue glucocorticoid reactivation in fat mobilization.
膳食脂肪摄入量增加与肥胖、胰岛素抵抗和代谢性疾病有关。在转基因小鼠中,脂肪组织特异性过表达糖皮质激素放大酶 11β-羟类固醇脱氢酶 1 型(11β-HSD1)加剧高脂肪(HF)饮食诱导的内脏肥胖和糖尿病,而 11β-HSD1 基因敲除则改善了这一点,有利于非内脏脂肪的积累。矛盾的是,在正常小鼠中,HF 饮食诱导的肥胖(DIO)与脂肪组织 11β-HSD1 水平的显著下调有关。为了确定调节脂肪组织 11β-HSD1 的特定膳食脂肪,从而影响代谢性疾病,我们要么让小鼠自由进食富含饱和(硬脂酸盐)、单不饱和(油酸盐)或多不饱和(红花油)脂肪的饮食(占总热量的 45%),要么让它们配对进食低脂肪(11%)对照饮食 4 周。测定脂肪和肝脏质量以及糖皮质激素受体和 11β-HSD1mRNA 和活性水平。硬脂酸盐导致体重减轻和胰岛素血症,部分原因是吸收不良,这显著增加了血浆皮质酮水平和脂肪 11β-HSD1 活性。油酸盐诱导明显的体重增加和高胰岛素血症,与明显低的血浆皮质酮和脂肪 11β-HSD1 活性有关。与油酸盐相比,红花油的体重增加和高胰岛素血症不那么明显,尽管血浆皮质酮和脂肪 11β-HSD1 受到类似的抑制。然而,通过配对喂养,红花油选择性地减少内脏脂肪量,相对胰岛素敏感性增加,而不影响血浆皮质酮或脂肪 11β-HSD1。脂肪组织 11β-HSD1 与脂肪量之间的动态库选择性关系强烈暗示局部组织糖皮质激素再激活在脂肪动员中具有主导的生理作用。